Riddhiman Das, Co-founder and CEO, TripleBlind
Cecil Lynch, Chief Medical Information Officer, Accenture
On May 25, Das and Lynch will discuss Accenture’s collaboration with TripleBlind and how the healthcare industry can use data sharing to speed up innovation, predict future diagnosis, and reduce complexities associated with internal and external data sharing, which often includes sensitive PII.
Private data sharing between organizations can facilitate rapid innovation in healthcare, especially by enabling AI development using previously inaccessible data. TripleBlind accelerates data sharing and collaboration and creates efficiencies by dramatically reducing arduous processes, long delays and high costs often involved with data sharing today.
Tuesday, May 25, 2021
Strategies for Advancing Healthcare Innovation by Keeping Sensitive
12:00 pm (CT)
Participants can register for the webinar here.
TripleBlind’s patented breakthroughs in advanced mathematics arm organizations with the ability to share, leverage and monetize regulated data, such as PII and PHI, and mission-critical enterprise data, such as tax returns and banking transactions. It unlocks the estimated 105 petabytes of data stored by enterprises today that are inaccessible and unmonetized due to privacy concerns and regulations. With TripleBlind, decision-makers generate new revenue for their organizations by gaining deeper insights faster, creating improved modeling and analysis, and collaborating more effectively with customers and partners and even competitors, while enabling enterprises to enforce today’s regulatory standards, such as HIPAA, GDPR and PDPA.
For more information, please visit tripleblind.ai.